Latest Breaking News On - Annette bakker - Page 1 : comparemela.com

Medicines momentum: Europe sets stage for improved clinical trials

US investment boosts Healx in start to transformational 2024

Healx co-founder and CEO Tim Guilliams is predicting a blockbusting 2024 for the Cambridge-based rare disease AI specialist following a major investment boost from the US.

Children's Tumor Foundation invests in Healx to advance Neurofibromatosis Type 1 treatments

/PRNewswire/ Healx, the AI-powered, patient-inspired, techbio company pioneering the next generation of drug discovery, today announced that it has signed.

Patients of genetic tumor condition gather in San Antonio for world's biggest NF patient summit

NF affects one in every 2,000 people. All patients are born with it, but some don't show symptoms until they are young adults. For those patients, it can be hard to diagnose.

Clinical Challenges: Hope and Caution in the Neurofibromatosis Drug Pipeline

Rare condition is starting to see potential for treatment options beyond the sole approved drug